» Articles » PMID: 27258544

Meta-Analysis of EMT Datasets Reveals Different Types of EMT

Overview
Journal PLoS One
Date 2016 Jun 4
PMID 27258544
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

As a critical process during embryonic development, cancer progression and cell fate conversions, epithelial-mesenchymal transition (EMT) has been extensively studied over the last several decades. To further understand the nature of EMT, we performed meta-analysis of multiple microarray datasets to identify the related generic signature. In this study, 24 human and 17 mouse microarray datasets were integrated to identify conserved gene expression changes in different types of EMT. Our integrative analysis revealed that there is low agreement among the list of the identified signature genes and three other lists in previous studies. Since removing the datasets with weakly-induced EMT from the analysis did not significantly improve the overlapping in the signature-gene lists, we hypothesized the existence of different types of EMT. This hypothesis was further supported by the grouping of 74 human EMT-induction samples into five distinct clusters, and the identification of distinct pathways in these different clusters of EMT samples. The five clusters of EMT-induction samples also improves the understanding of the characteristics of different EMT types. Therefore, we concluded the existence of different types of EMT was the possible reason for its complex role in multiple biological processes.

Citing Articles

Differentiation stage-specific expression of transcriptional regulators for epithelial mesenchymal transition in dentate granule progenitors.

Ohyama K, Shinohara H, Takayama N, Ogawa R, Omura S, Hayashida M Front Neurosci. 2024; 18:1425849.

PMID: 39268037 PMC: 11390541. DOI: 10.3389/fnins.2024.1425849.


Two-Dimensional-PAGE Coupled with nLC-MS/MS-Based Identification of Differentially Expressed Proteins and Tumorigenic Pathways in MCF7 Breast Cancer Cells Transfected for JTB Protein Silencing.

Jayathirtha M, Jayaweera T, Whitham D, Sullivan I, Petre B, Darie C Molecules. 2023; 28(22).

PMID: 38005222 PMC: 10673289. DOI: 10.3390/molecules28227501.


Mechanisms of tumor-associated macrophages affecting the progression of hepatocellular carcinoma.

Yuan Y, Wu D, Li J, Huang D, Zhao Y, Gao T Front Pharmacol. 2023; 14:1217400.

PMID: 37663266 PMC: 10470150. DOI: 10.3389/fphar.2023.1217400.


Nuclear localization of TET2 requires β-catenin activation and correlates with favourable prognosis in colorectal cancer.

Li C, He J, Meng F, Wang F, Sun H, Zhang H Cell Death Dis. 2023; 14(8):552.

PMID: 37620362 PMC: 10449923. DOI: 10.1038/s41419-023-06038-x.


Constitutive Occurrence of E:N-cadherin Heterodimers in Adherens Junctions of Hepatocytes and Derived Tumors.

Gerber T, Ridder D, Schindeldecker M, Weinmann A, Duret D, Breuhahn K Cells. 2022; 11(16).

PMID: 36010583 PMC: 9406782. DOI: 10.3390/cells11162507.


References
1.
Garg M . Epithelial-mesenchymal transition - activating transcription factors - multifunctional regulators in cancer. World J Stem Cells. 2013; 5(4):188-95. PMC: 3812522. DOI: 10.4252/wjsc.v5.i4.188. View

2.
Dalerba P, Cho R, Clarke M . Cancer stem cells: models and concepts. Annu Rev Med. 2006; 58:267-84. DOI: 10.1146/annurev.med.58.062105.204854. View

3.
Wellner U, Schubert J, Burk U, Schmalhofer O, Zhu F, Sonntag A . The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol. 2009; 11(12):1487-95. DOI: 10.1038/ncb1998. View

4.
Rawluszko-Wieczorek A, Siera A, Jagodzinski P . TET proteins in cancer: Current 'state of the art'. Crit Rev Oncol Hematol. 2015; 96(3):425-36. DOI: 10.1016/j.critrevonc.2015.07.008. View

5.
Zhao M, Kong L, Liu Y, Qu H . dbEMT: an epithelial-mesenchymal transition associated gene resource. Sci Rep. 2015; 5:11459. PMC: 4477208. DOI: 10.1038/srep11459. View